# Post-Traumatic Brain Injury (Post-TBI) Fatigue and Its Treatment

> **NCT00233090** · PHASE2 · TERMINATED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 21 (actual)

## Conditions studied

- Fatigue

## Interventions

- **DRUG:** Modafinil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00233090
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-07
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Insufficient recruitment
- **Last updated:** 2016-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00233090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00233090, "Post-Traumatic Brain Injury (Post-TBI) Fatigue and Its Treatment". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00233090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*